1
SECURITIES AND EXCHANGE COMMISSION
450 Fifth Street, N.W.
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: April 28, 1995
Atrix Laboratories, Inc.
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 0-18231 84-1043826
- ------------------- ------------------- ----------------
(State of (Commission (IRS Employer
incorporation) File Number) Identification No.)
2579 Midpoint Drive, Fort Collins, Colorado 80525
----------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (970)482-5868
Not Applicable
--------------
(Former Name or Former Address, if Change Since Last Report)
2
Item 5. Other Events.
See the Press Releases attached hereto as Exhibit 20.1 and Exhibit 20.2.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
20.1. Press Release dated April 28, 1995 regarding the
signing of a License Agreement with Paravax, Inc.
20.2. Press Release dated May 2, 1995 regarding the
signing of a License Agreement with Gensia, Inc.
3
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ATRIX LABORATORIES, INC.
Date: May 10, 1995 By: /s/ Kimberly A. Marks
---------------------------------------
Kimberly A. Marks, Corporate Controller
4
EXHIBIT INDEX
EXHIBIT NO. EXHIBIT DESCRIPTION PAGE
- ----------- -------------------- ----
20.1. Press Release dated April 28, 1995 regarding the
signing of a License Agreement with Paravax, Inc.
20.2. Press Release dated May 2, 1995 regarding the
signing of a License Agreement with Gensia, Inc.